This post was originally published on this site
Shares of the Deerfield, Illinois-based company rose nearly 3% to $55.5 in trading before the bell.
Walgreens administered 15.6 million vaccinations and 6.5 million tests in the quarter ended Nov. 30, helping U.S. same-store retail sales jump 10.6% – the highest in over 20 years.
Governments and health authorities around the world are pushing for increased vaccinations and testing as the fast-spreading Omicron coronavirus variant threatens to disrupt industries and overburden healthcare systems.
Walgreens increased its full-year adjusted profit expectations to low-single digit growth, from flat previously.
Same-store sales at its Boots UK retail stores increased 16.3% from a year earlier. Footfall at the unit had suffered a major hit during the COVID-19 crisis in 2020.
Excluding items, Walgreens earned $1.68 per share, compared with Refinitiv IBES estimates of $1.33.
Revenue rose 7.8% to $33.9 billion, beating analysts’ estimate of $32.74 billion.
